documents: FDA-2016-N-0001-0042

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2016-N-0001-0042 FDA FDA-2016-N-0001 Endocrinologic and Metabolic Drugs Advisory Committee; Amendment of Notice Notice Announcement 2016-04-06T04:00:00Z 2016 4 2016-04-06T04:00:00Z   2016-04-06T14:42:32Z 2016-07906 0 0 0900006481f2e227

Links from other tables